ProfoundBio is an oncology biotherapeutics company that develops novel antibody-based therapeutics for cancer patients.
Industry
Sector :
Subsector :
founded date
01.01.2018
Last funding type
Series B
IPO status
Private
Description
ProfoundBio is a clinical stage biotherapeutics company that aims to provide better treatment options for cancer patients. Their targeted therapeutics are designed to harness the power of the immune system to fight cancer and potentially provide a cure. With a focus on antibody-based therapeutics, ProfoundBio is at the forefront of developing innovative treatments for oncology patients.